Timothy Wylie, DPM
Foot & Ankle Surgery · Cincinnati, OHNPI 1457770703
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $14,072 of the $22,456 with a category attached, or 62.7%. Stryker accounts for 68.2% of it on its own, with 33 other manufacturers making up the rest. Reporting peaked in 2019 at $9,477 and has fallen 92.4% since, to $720 in 2025.
Across 307 payments — averaging $73.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$15K
- Osteomed LLC$2K
- CDC Medical LLC$1K
- Legacy Ortho LLC$1K
- Smith+Nephew$379
- Amgen$262
- plus $2K from 28 others
What the payments were for
- Speaking & faculty fees$1,5007%
- Travel & lodging$4,28619%
- Food & beverage$14,07263%
- Education$2,59812%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker(2 entities) | 231 | $15,312 |
| Osteomed LLC | 1 | $1,500 |
| CDC Medical LLC | 1 | $1,398 |
| Legacy Ortho LLC | 1 | $1,200 |
| Smith+Nephew | 16 | $379 |
| Amgen(2 entities) | 3 | $262 |
| Zimmer Biomet | 4 | $258 |
| Bioventus LLC | 4 | $226 |
| Paragon 28, Inc. | 3 | $216 |
| Sanara Medtech Inc. | 3 | $211 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $152 |
| Nevro Corp. | 6 | $145 |
| Shockwave Medical, Inc | 1 | $128 |
| Angiodynamics, Inc. | 1 | $125 |
| Bone Support Inc. | 1 | $120 |
| Cordis US CORP. | 1 | $107 |
| KCI USA, Inc. | 2 | $94 |
| Convatec Inc. | 4 | $93 |
| Integra Lifesciences Corporation | 1 | $90 |
| Paratek Pharmaceuticals, Inc. | 4 | $70 |
| Organogenesis Inc. | 2 | $54 |
| Treace Medical Concepts, Inc. | 2 | $48 |
| Trilliant Surgical LLC. | 1 | $47 |
| Kerecis Limited | 1 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Melinta Therapeutics, LLC | 2 | $29 |
| Acera Surgical, Inc. | 1 | $22 |
| Biotissue Holdings Inc. | 1 | $20 |
| Solventum Corporation | 1 | $20 |
| Mimedx Group, Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $14 |
| Trice Medical, Inc. | 1 | $14 |
| Merck | 1 | $11 |
| Alfasigma USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STAR$1,770
- EXT-Extremifuse$1,500
- EXT-Encompass$1,500
- EXT-Extremilock Foot$1,500
- EXT-ExtremiLock Ankle$1,500
- EXT-ExtremiFix Midsize/Large$1,500
- HOFFMANN$1,441
- PRIME SERIES$1,388
- VARIAX$805
- ORTHOLOC 3DI$790
- FIXOS$748
- ASNIS$716
- CITREFIX$609
- ANCHORAGE$597
- Viaflow$579
- ORTHOLOC 2 LAPIFUSE$521
- PROLAYER$483
- ALLOGRAFT$478
- AUGMENT INJECTABLE$446
- SONICANCHOR$312
How this compares
$22,456 in reported general payments places this provider in the 85th percentile of 429 foot & ankle surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 12 | $6,162 |
| Ciclopirox | 48 | $1,695 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 52 | $1,463 |
| Ammonium Lactate | 78 | $1,141 |
| Clotrimazole | 17 | $552 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 43 | $398 |
| Gabapentin | 33 | $363 |
| Terbinafine Hcl | 25 | $304 |
| Doxycycline Hyclate | 43 | $295 |
| Doxycycline Monohydrate | 16 | $199 |
| Mupirocin | 31 | $173 |
| Methylprednisolone | 29 | $157 |
| Clindamycin Hcl | 11 | $137 |
| Levofloxacin | 12 | $59 |
| Meloxicam | 17 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $379 | $6,16212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 429 foot & ankle surgery providers in Ohio.
Other foot & ankle surgery in Cincinnati
- Robert BrarensCincinnati$108K
- Casie BlantonCincinnati$17K
- Christopher HyerWorthington$4.7M
- Thomas LeePickerington$4M
- Jordan GrossmanAkron$2.5M
- Robert GorslineHilliard$1.4M
- Jonathan FeibelGahanna$1.4M
- Mark PrisselWorthington$1.2M
- Lee HladGahanna$440K
- Windy ColeKent$431K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.